Sort
46,585 grants matching “heart failure”
Pulmonary hypertension: Genetic, Microbiome and Environmental Determinants
$443,765Alison Morris · University Of Pittsburgh At Pittsburgh · P01 · FY2019 · HL
HDL Heterogeneity and Function, Statin Therapy, and CVD Outcomes
$443,750Samia Mora · Brigham And Women'S Hospital · R01 · FY2016 · HL
Collagen Accumulation & Mechanical Mechanisms in Pulmonary Hypertension
$443,696Naomi C Chesler · University Of Wisconsin-Madison · R01 · FY2014 · HL
Clutter Suppression in Echocardiography Using Short-Lag Spatial Coherence Imaging
$443,543Jeremy Dahl · Stanford University · R01 · FY2018 · EB
Mechanisms of GalTKO Lung Xenograft Injury
$443,543Richard N Pierson · University Of Maryland Baltimore · U01 · FY2008 · AI
Molecular drivers of tissue-specific morphogenetic programs
$443,501Margot L.k. Williams · Baylor College Of Medicine · R01 · FY2023 · HD
Molecular drivers of tissue-specific morphogenetic programs
$443,501Margot L.k. Williams · Baylor College Of Medicine · R01 · FY2025 · HD
Molecular drivers of tissue-specific morphogenetic programs
$443,501Margot L.k. Williams · Baylor College Of Medicine · R01 · FY2022 · HD
PCSK9 Inhibition after Heart Transplantation
$443,451William F Fearon · Stanford University · R33 · FY2022 · HL
Engineering of Human Excitable Tissues from Unexcitable Cells
$443,377Nenad Bursac · Duke University · R01 · FY2017 · HL
Precision Medicine Approach to Vitamin D3 Administration in Critical Illness
$443,359David Evan Leaf · Brigham And Women'S Hospital · R01 · FY2022 · HL
Genetic Engineering of Vein Bypass Grafts in Vascular and Cardiovascular Surgery
$443,337Frank W Logerfo · Beth Israel Deaconess Medical Center · R01 · FY2010 · HL
Immune effects of ACE over-expression in neutrophils
$443,250Kenneth E Bernstein · Cedars-Sinai Medical Center · R01 · FY2018 · AI
Multiscale Modeling for Treatment Discovery in Duchenne Muscular Dystrophy
$443,243Silvia Salinas Blemker · University Of Virginia · U01 · FY2020 · AR
HIMF/FIZZ1 IN PULMONARY HYPERTENSION/RIGHT HEART FAILURE
$443,241Roger A Johns · Johns Hopkins University · P50 · FY2011 · HL
Planning a Multicenter Trial of PDE5A Inhibition for Duchenne Muscular Dystrophy
$443,226Ronald G Victor · Cedars-Sinai Medical Center · U34 · FY2012 · AR
Ca2+ Regulation in Newly Formed Ventricular Myocytes
$443,191Steven R Houser · Temple Univ Of The Commonwealth · R37 · FY2010 · HL
Determinants of cardioprotection by circulating prohibitin-1 during sepsis
$443,182Ethan John Anderson · University Of Iowa · R01 · FY2025 · HL
Substrate Selection and Oxidative Stress in Heart Failure
$443,091Fabio A Recchia · Henry Ford Health System · P01 · FY2013 · HL
Plasma sphingolipids and risk of cardiovascular disease
$443,040Rozenn Lemaitre · University Of Washington · R01 · FY2018 · HL
Zinc Protection Against Ischemia-Reperfusion Injury in Heart
$443,022Zui Pan · University Of Texas Arlington · R15 · FY2023 · HL
Translational Pulmonary Vascular Biology Program
$443,010Kurt R Stenmark · University Of Colorado Denver · T32 · FY2020 · HL
PEG hydrogels for progenitor cell delivery
$442,977Michael E Davis · Emory University · R01 · FY2018 · HL
Regulation of Cardiac Death and Energy Metabolism by MCL-1
$442,948Joseph T. Opferman · St. Jude Children'S Research Hospital · R01 · FY2017 · HL
Mitochondrial R-loop in sepsis-induced cardiomyopathy
$442,907Wei Huang · University Of Cincinnati · R01 · FY2024 · HL